Embecta Corp
(NAS:EMBC)
$
3.305
-0.045 (-1.34%)
Market Cap: 196.08 Mil
Enterprise Value: 1.37 Bil
PE Ratio: 1.74
PB Ratio: 0
GF Score: 53/100 Embecta Corp at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 06:55PM GMT
Release Date Price:
$16.71
(+3.34%)
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate
Perfect. Thank you, everyone, for coming. Very pleased to have the team from Embecta. Here today, we've got Dev, CEO; Jake, CFO; and Pravesh from IR here as well.
Just before I get started, I've got to read you some disclosures briefly. Any disclosures regarding this conference, please see www.morganstanley.com/researchdisclosures or please contact your Morgan Stanley sales representative.
Questions & Answers
Kallum L Titchmarsh
Morgan Stanley, Research Division - Research Associate
So Dev, I [wanted] to start today just touching on the pretty solid fiscal year Q3 performance recently. And maybe you provide some high-level takes from that and the key drivers there?
Devdatt Kurdikar
Embecta Corp. - President, CEO & Director
Yes, happy to do that. First of all, thank you for having us, Kallum. Strong quarter. Really pleased with
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot